The endocrinologist weighs the promise of GLP-1 drugs against the need for medical caution in an exclusive talk.
Recap by typeshit. Post by @IndiaToday on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
An explainer on how appetite and weight can change after coming off GLP-1 drugs, and why any taper should be done with a doctor guiding it.
Researchers identified the patient groups most likely to benefit before starting treatment, giving employers a clinical basis for coverage as costs climb.
Loading…